Government ❯ Health Policy ❯ FDA Regulations

Vaccine Approval Process

Public Health Recommendations Moderna Vaccine Approval Risk Assessment Public Health Advisory Panels Vaccine Guidance Post-Marketing Commitments

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women